Egol, Michael Jr M.

HRN: 29-39-30  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/28/2026
08/04/2026
IV
500mg
Q8
Acute AP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: